Sigachi Laboratories LimitedUnlisted Shares
₹ 52▲0.00%(0.00)
About the company
Sigachi Laboratories Limited is an Indian pharmaceutical company engaged in the manufacturing and supply of bulk drugs, drug intermediates, and pharmaceutical products. The company operates from its registered office and manufacturing facility in Sangareddy District, Telangana, and has established its presence in the pharmaceutical sector by focusing on quality manufacturing, regulatory compliance, and operational efficiency.
The company's core business revolves around producing pharmaceutical ingredients that serve as essential building blocks in the manufacturing of medicines. In addition to its pharmaceutical operations, Sigachi Laboratories also generates income from interest on loans, inter-corporate deposits (ICDs), and fixed deposits, contributing to its overall financial performance.
Fundamentals
Valuation
- 52 week high
- ₹52
- 52 week low
- ₹52
- P/B ratio
- 0.89
- Debt to equity
- 0
- ROE (%)
- 3.03%
- Book value
- ₹58.39
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE368H01018
Figures in lk ·
Financials
| P&L Statement | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 176.24 | 169.54 | 66 | 348 | 260 | 195 | 374 | 312 |
| EBITDA | 113.64 | 113.89 | 25 | 293 | 211 | 142 | 242 | 109 |
| OPM | 64.48 | 67.18 | 37.88 | 84.2 | 81.15 | 72.82 | 64.71 | 34.94 |
| PBT | 133.89 | 127.39 | 116 | 314 | 238 | 173 | 281 | 152 |
| PAT | 111.1 | 104.51 | 70 | 276 | 200 | 131 | 197 | 119 |
| EPS | 1.52 | 1.43 | 0.96 | 3.78 | 2.74 | 1.79 | 2.69 | 1.63 |
Shareholding Pattern
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Sri. T. Adinarayana | Chairman | 30+ yrs experience | — |
| Sri. T.R. Sekhar | Executive Director | 25+ yrs experience | — |
| Mr. B. Kumar | CFO | 25+ yrs experience | — |
Frequently asked questions
Common questions on Sigachi Laboratories Limited Unlisted Shares—tap a row to read the answer.
Q.1What is Sigachi Laboratories Limited?
Sigachi Laboratories Limited is an Indian pharmaceutical company engaged in the manufacturing of bulk drugs, drug intermediates, and other pharmaceutical products. The company also earns income from interest-bearing investments such as inter-corporate deposits (ICDs), loans, and fixed deposits. With its focus on quality manufacturing and operational efficiency, the company serves the pharmaceutical industry's growing demand for active ingredients and intermediates.
Q.2Can I invest in Sigachi Laboratories Limited unlisted shares?
Yes, if Sigachi Laboratories Limited unlisted shares are available in the private market, eligible investors can purchase them through private share transactions. Since these shares are not traded on major stock exchanges, their availability depends on existing shareholders willing to sell and prevailing market demand.
Q.3How can I buy Sigachi Laboratories Limited unlisted shares?
You can buy Sigachi Laboratories Limited unlisted shares through authorized intermediaries that facilitate private share transactions. Once the price, quantity, and documentation are finalized, the shares are transferred electronically to your Demat account after successful payment and verification.
Q.4How is the price of Sigachi Laboratories Limited unlisted shares determined?
The price of Sigachi Laboratories Limited unlisted shares is generally influenced by several factors, including the company's financial performance, profitability, business outlook, pharmaceutical industry trends, recent private market transactions, investor demand, and overall market sentiment. Since the shares are privately traded, prices are determined through negotiations rather than exchange-based trading.
Q.5Is it legal to buy Sigachi Laboratories Limited unlisted shares in India?
Yes. Buying and selling unlisted shares is legal in India when the transaction complies with applicable laws and regulatory requirements. Investors should ensure that the transfer is completed with proper documentation and that the shares are credited to their Demat account.
Q.6Do I need a Demat account to hold Sigachi Laboratories Limited unlisted shares?
Yes. An active Demat account is generally required to receive and hold Sigachi Laboratories Limited unlisted shares in electronic form. It provides secure ownership records and makes future transfers or sales more convenient.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
